Please Wait a Moment
X

Articles

07Aug

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- August 8th Update

07 Aug, 2018 | Return|

CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.

Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications

Related

Reminder- Check flights and cargo hours for the Thanksgiving Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

CTS Dallas and Phoenix Labs Implements WNV Testing on the Panther

CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...

Read More >

Shipping conditions for Monolisa anti-HBs EIA

After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...

Read More >

CTS Dallas Implements New Laboratory Information System

On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...

Read More >

Special Testing Laboratory Test Result Reporting Change

An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...

Read More >

October 20th Update on Ortho Conversion

The revised CTS algorithm associated with the Ortho platform is now available for review.  Clie...

Read More >